IFNG and malaria: Previous vaccine studies using these vectors in human prime-boost regimes with much smaller inserts have demonstrated the ability to induce strong T-cell responses measured by the ex vivo IFNγ-ELISPOT and induce sterile protection on malaria challenge in some volunteers [7].